Skip to contentSkip to Braille Studio

Library / Laws / 115th Congress / Senate Bills / S. 2022

S. 2022

To amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2017-10-267.0K⠃⠗⠋